BioAscent
Newhouse, United Kingdombioascent.comFrom their website, Nov 2026
Work here? Claim this listing
About
BioAscent is a drug discovery CRO based in Newhouse, Scotland, UK. It provides integrated discovery services for biopharma customers, including assay development, screening, medicinal and synthetic chemistry, computational chemistry, protein production, structural biology, and compound management. The company also manages customer compound libraries and supports projects from target work through to preclinical and clinical candidates.
Services
De novo assay development
Designs and develops new assays for drug discovery projects.
Assay optimisation and miniaturisation
Optimises existing assays and scales them down for efficient screening.
Biochemical, biophysical and cellular assay development
Develops bespoke biochemical, biophysical, and cellular assays for target interrogation and hit identification.
Target analysis & bespoke screening strategies
Designs and interprets assay cascades and screening strategies for a target.
Compound screening
Runs screening campaigns including HTS, MTS, fragment, focused, iterative, diversity-based and virtual screening.
Medicinal chemistry
Designs and synthesises ligands through hit generation, hit-to-lead, and lead optimisation.
Synthetic chemistry
Provides route design and tailored synthesis, including building blocks, multi-step synthesis, asymmetric synthesis, parallel synthesis, and reference molecules.
In silico discovery and AI
Applies computational chemistry, CADD, cheminformatics, modelling, and data analysis to drug discovery projects.
15 more services
- Physicochemical profiling & DMPK
- Protein production
- Surface plasmon resonance (SPR) & biophysics
- Structural biology
- Compound management
- In-house diversity, fragment & chemogenomic libraries
- External library selection & sourcing
- Mitochondrial biology
- Gpcr drug discovery
- Accelerating CNS drug discovery
- Integrated drug discovery
- Bespoke assay development
- Mitochondrial biology in drug discovery
- CNS drug discovery
- Biochemical, Biophysical & Cellular Assay Development
- What to send
- Protein samples
- Compound libraries
- Customer compounds
- Target or structure information for custom library design
- Compound libraries in liquid and solid formats
Capabilities
As they state on their website or in their listing.
- Processes
- Small molecule
- Recombinant protein
- SPR
- HTS
- ADME
- Capacity
- 125K IP-free molecules
- 86,000 compounds held as solid stock
- Over 1.5 million compounds managed for customers
- Libraries of up to 250k in size
- 96-well plates
- 384-well plates
13 more
- 1536-well plates
- Three individually housed, environmentally controlled -20°C stores
- In-house diversity library of 125K IP-free molecules
- 86,000 compounds also held as solid stock
- Multiple HTS and fragment screens using libraries of up to 250k in size
- Three individually housed environmentally controlled -20°C stores
- 96, 384 and 1536-well plate formats
- Libraries up to 250k in size
- Over 100,000 screening plates
- 96-well plate formats
- 384-well plate formats
- 1536-well plate formats
- Three individually housed -20°C stores
- Data supplied
- NMR · LC-MS
Equipment
- Biacore 8K
- Seahorse XF
- LC-MS
- UPLC
- SFC
- NMR
- Diamond Light Source synchrotron
- Mosaic from Titian
- Robotic systems
- Surface plasmon resonance (SPR)
Industries served
- Biotechnology
- Pharmaceutical
- Academia
Details
- Type
- CRO
- Founded
- 2013
- Based in
- Newhouse, United Kingdom
- Serves
- Around the world, customers from around the world, global customers, partners
- Phone
- +44 (0) 1698 534002